跳至主要内容
临床试验/NCT02835274
NCT02835274已完成不适用

Directional Lead: Investigation of Rotational Current Steering, Ease of Use of Clinical Effects Map, and Therapeutic Outcomes of Deep Brain Stimulation

Boston Scientific Corporation3 个研究点 分布在 3 个国家目标入组 12 人开始时间: 2016年7月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
3
主要终点
Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS) Scores - Motor Section (Part III) at End of Randomized Phase

研究概览

简要总结

The primary objective is to characterize the programming effects of Boston Scientific Vercise™ PC System using the DBS Directional Lead for bilateral STN DBS for the treatment of Parkinson's disease in acute and chronic settings.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Double (Participant, Outcomes Assessor)

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis of bilateral idiopathic PD with the presence of rigidity and at least one (1) of the following: resting tremor or bradykinesia.
  • UPDRS III score of >25 in the meds OFF condition
  • Medication must improve PD symptoms by ≥30%, as measured by UPDRS subset III score

排除标准

  • Any significant psychiatric problems, including unrelated clinically significant depression as determined by the investigator
  • Any current drug or alcohol abuse as determined by the investigator
  • Any history of recurrent or unprovoked seizures
  • Any significant medical condition that is likely to interfere with study procedures or likely to confound evaluation of study endpoints, including any terminal illness with survival <12 months

结局指标

主要结局

Mean Change in Unified Parkinson's Disease Rating Scale (UPDRS) Scores - Motor Section (Part III) at End of Randomized Phase

时间窗: Up to 12 months post-implant

Mean change in Unified Parkinson's Disease Rating Scale (UPDRS) scores - motor section (Part III) at end of randomized phase in meds ON condition Range of UPDRS III is 0 - 108 with greater scores indicating worse disease state

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验